Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia
Status:
Terminated
Trial end date:
2018-07-14
Target enrollment:
Participant gender:
Summary
RATIONALE: Romiplostim may cause the body to make platelets.
PURPOSE: This randomized phase II trial is studying how well romiplostim works in treating
hepatitis C-infected patients with thrombocytopenia.